Life Insurance
Consensus Index

AI Consensus Fit Review

Transamerica No-Medical-Exam Final Expense Insurance Fit Review

Transamerica is a good, but not clearly best, fit for No-Medical-Exam Final Expense Insurance.

Research: 2026-09-217 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Transamerica is a good, but not clearly best, fit for No-Medical-Exam Final Expense Insurance. All 7 platforms named Transamerica during ranking discovery, and 6 of 7 returned a usable fit assessment — five rated it "good" and one rated it "mixed." The strongest reason to consider it is a simplified-issue whole life portfolio (Immediate Solution, 10-Pay Solution, Easy Solution, and FE Express Solution) that Transamerica markets as potentially approving applicants without exams or labs, with decisions advertised in as little as 10 minutes. The main limitation is that no-exam is not guaranteed issue: Transamerica reserves the right to request exams and additional medical data, and product naming, pricing, state availability, and complaint data require verification before purchase.

Research Snapshot

FieldFinding
Platform mentions in ranking stage7 of 7 included platforms (anthropic, deepseek, google, grok, kimi, openai, perplexity)
Share of included platform responses100% named Transamerica during ranking discovery
Average listed rank3.86
Best listed rank2 (openai, perplexity)
Relevant product/model/planFinal Expense Solutions: Immediate Solution, 10-Pay Solution, Easy Solution; FE Express Solution / Express Select; Express Protect Underwriting with iGO e-App
Overall use-case fitGood (5 platforms), mixed (1 platform); 6 of 7 platforms returned a usable fit assessment
Research date2026-09-21

Why Transamerica Qualified for This Study

Questions This Section Answers

  • Why did AI platforms recommend Transamerica for no-medical-exam final expense insurance?
  • Is Transamerica a reputable carrier for permanent final expense coverage without a paramedical exam?

Transamerica qualified because it directly addresses the buyer's core requirement — permanent final expense coverage without a traditional blood-and-urine paramedical examination — and because every platform in the ranking stage named it. Transamerica's Final Expense Solutions portfolio is described as simplified-issue whole life with face amounts from $1,000 to $50,000, guaranteed level premiums, and a guaranteed death benefit [1]. The company markets Express Protect Underwriting with its iGO e-App as offering the potential for same-day approval without exams or labs [2].

Independent financial-strength evidence supports consideration: AM Best lists Transamerica life insurance Company at A (Excellent) with a stable outlook, affirmed effective February 13, 2026 [3]. Multiple independent reviews repeat the A (Excellent) rating [4].

The qualification is not unconditional. Transamerica's own press release states the product is not guaranteed issue and that the underwriter reserves the right to request additional medical exams and data [7]. That single disclosure is the most important fact in this review.

The Product, Model, Plan, or Service Most Relevant to No-Medical-Exam Final Expense Insurance

Questions This Section Answers

  • Which Transamerica plan should a buyer choose for no-medical-exam final expense coverage: Immediate Solution, 10-Pay Solution, or Easy Solution?
  • Does Transamerica FE Express Solution really approve coverage without a medical exam?

The most relevant offer is Transamerica's Final Expense Solutions portfolio, distributed under several names that do not fully reconcile across sources. The reviewed official materials identify three products: Immediate Solution, 10-Pay Solution, and Easy Solution [9]. Independent and platform-reported sources instead emphasize FE Express Solution and Express Select [10]. The relationship among these names is unclear and should be confirmed with the agent as possible distribution or legacy terminology [9].

Where the sources agree is on structure. The products are simplified-issue whole life. Immediate Solution and 10-Pay Solution provide face amounts from $1,000 to age-based maximums of $25,000 to $50,000; Easy Solution is a graded-benefit product with a maximum face amount of $25,000 [9]. Independent reviews describe FE Express Solution as offering $5,000 to $100,000 for ages 18–75, with limits reduced for older applicants [13]. That coverage-ceiling discrepancy — $50,000 versus $100,000 — is unresolved in the supplied evidence.

Premium design differs by product. Immediate Solution and Easy Solution use level premiums to age 121 and mature at age 121; 10-Pay Solution uses level premiums for 10 years and also matures at age 121 [9]. Easy Solution limits the non-accidental death benefit during the first two policy years to 110% of premiums paid, less any loan balance [9].

What the AI Platforms Agreed About

Questions This Section Answers

  • Do AI platforms agree that Transamerica is a good fit for no-medical-exam final expense insurance?
  • What do reviewers agree Transamerica does well for buyers who want permanent coverage without blood or urine testing?

Six platforms returned a usable fit assessment, and the areas of agreement are consistent. Five rated Transamerica "good" (anthropic, deepseek, grok, openai, perplexity) and one rated it "mixed" (kimi). This is a strong majority, not unanimity, and platform agreement does not prove product quality.

Platforms agreed on four points:

No-exam simplified issue is real but not guaranteed. Every platform described the products as simplified issue using health questions and available records rather than a paramedical exam [16]. Every platform also flagged that underwriting can escalate. Transamerica's own materials confirm the underwriter may request additional exams and data [21].

Coverage is permanent whole life with level premiums. Platforms consistently described guaranteed level premiums that do not increase with age, and a guaranteed death benefit for life as long as premiums are paid [23].

Application speed is a genuine differentiator. Transamerica advertises decisions in as little as 10 minutes with electronic policy delivery [26]. This is company-reported marketing, repeated by independent reviewers.

Carrier strength is favorable. AM Best's A (Excellent) rating is the strongest independent evidence in the file [29].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • What are the biggest uncertainties about Transamerica final expense that a buyer should resolve before applying?
  • Is Transamerica's customer complaint record a reason to avoid its final expense products?

Four material disagreements or gaps appear in the supplied evidence.

Product naming is unresolved. Ranking-stage names include Express Select, FE Express Solution, Final Expense Immediate Solution, and Final Expense Whole Life, while reviewed official materials use Immediate Solution, 10-Pay Solution, and Easy Solution [30]. No source reconciles these names.

Pricing is opaque and inconsistent. Consumer-specific premiums are not publicly disclosed in the reviewed materials [30]. Sample figures conflict: one independent review cites $61 per month for a 65-year-old female non-smoker at Select class for $10,000 of coverage [34], while another cites roughly $40.77 for a 65-year-old female at the same face amount [35]. These likely reflect different products and health classes, but the evidence does not establish that.

Complaint data is elevated and only partly attributable. One independent review reports a NAIC complaint index of 4.23 for individual life policies against a national average of 1.0 [36], and a 2025 complaint rate more than four times higher than expected [37]. Kimi reports litigation history including $57 million and $88 million class-action settlements tied to universal life lines, not final expense products [35]. Whether the complaint elevation applies to final expense policyholders specifically is unknown.

Underwriting escalation risk is real but unquantified. No source states how often simplified-issue applicants are referred to full underwriting, or what that costs in time.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Transamerica offer for a buyer who wants final expense coverage without a paramedical exam?
  • Does Transamerica final expense include riders, and are they available in every state?

The features most relevant to this use case are the underwriting pathway, the payment structures, and the rider set.

Underwriting pathway. Express Protect Underwriting with the iGO e-App is the relevant application process, marketed as offering potential same-day approval without exams or labs [38]. The electronic application is not available in New York according to the reviewed public page [38]. Independent sources state Transamerica pulls medical records and third-party data to decide no-exam coverage [39], which aligns with the buyer's stated willingness to allow record review.

Payment structures. Immediate Solution and Easy Solution use level premiums to age 121; 10-Pay Solution limits scheduled premium payments to 10 years [41]. Level premiums are guaranteed and do not increase with age [42].

Riders. Reported riders include a Concierge Planning Rider, Accelerated Death Benefit with Nursing Home Benefit, and Accidental Death Benefit Rider [44]. One source states the Funeral Concierge Rider is provided at no additional premium cost [45]. Transamerica states riders have specific limitations and are not available in all jurisdictions [46]. Easy Solution has no riders listed in the reviewed specification sheet [41].

Geographic limits. The reviewed state-availability flyer lists Final Expense Solutions as available in most states but shows exceptions or channel-specific restrictions, including Connecticut, New York, Puerto Rico, Guam, and the U.S. Virgin Islands [47]. One independent source states products are unavailable in New York [48]; another states availability in all 50 states plus DC [49]. This conflict is unresolved.

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Transamerica final expense cost per month, and what policy fees apply?
  • Are there cancellation, free-look, or surrender terms a buyer should confirm before signing?

Pricing confidence is low across platforms. No reviewed source provides verified consumer-specific premiums, and the most detailed fee document is an agent-facing specification sheet dated September 2022 [50].

Known cost elements from that specification sheet: an annual policy fee of $60 for face amounts below $5,000 and $42 for face amounts of $5,000 or more; modal factors of 0.086 monthly, 0.2575 quarterly, 0.51 semiannually, and 1.00 annually; and a policy-loan variable rate not to exceed 8% [50]. One broker product guide lists a $15 annual policy fee instead [51], which conflicts with the specification sheet.

Sample premium figures reported by platforms, none independently verified:

SourceScenarioReported premium
65F non-smoker, $10,000, Select class$61/month
Comparison to Mutual of OmahaTransamerica higher than $41/month
65F, $10,000, FE Express~$40.77/month
65M, $10,000, FE Express~$54/month
Company average annual premium$273 vs. $382 industry average

Contract terms: Immediate Solution and Easy Solution mature at age 121; 10-Pay Solution has a 10-year premium-paying period and matures at age 121 [50]. Easy Solution has a two-year graded death benefit for non-accidental death [50]. The reviewed materials do not state a specific free-look period, surrender-charge schedule, lapse-reinstatement terms, or cancellation-refund rules [50]. One platform notes whole life coverage is described as permanent with a guaranteed death benefit and that one product guide says coverage endows at age 100 [53] — a conflict with the age-121 maturity in the specification sheet.

Best Suited For

Questions This Section Answers

  • Who is Transamerica best suited for among buyers seeking no-medical-exam final expense coverage?
  • Is Transamerica a good choice for an applicant with conditions like diabetes or COPD who wants day-one coverage?

Transamerica is best suited for applicants who want permanent whole-life final expense coverage with level premiums, are willing to answer health questions and allow prescription or medical-record review, and value an electronic application with potential accelerated underwriting [54].

It is also a reasonable fit for applicants with moderate health complexity. One review panel rated Transamerica the most lenient for paired conditions such as insulin-dependent diabetes with COPD [57], and another notes Transamerica accepts conditions Mutual of Omaha declines [58]. Buyers who want to stop paying premiums sooner may prefer the 10-Pay Solution [54].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Transamerica for no-medical-exam final expense insurance?
  • Is Transamerica a poor choice for a buyer who needs guaranteed acceptance with no health questions?

Transamerica is probably not the best fit for buyers who need guaranteed acceptance with no health questions or underwriting [59]. It is also a weak fit for buyers who require publicly posted, buyer-specific premiums before applying [59], and for buyers in a state or distribution channel where the desired product is unavailable [62].

Buyers prioritizing the lowest possible premium should compare carefully: one source reports Transamerica rates 20–30% higher than Mutual of Omaha for comparable coverage [63], and another reports Express Select running 45–65% above Mutual of Omaha at Select class [65]. Buyers who weight customer-service reputation heavily should note the elevated complaint index [66]. Applicants with BMI 35 or higher are noted as having difficulty qualifying [68].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Transamerica if the buyer needs guaranteed acceptance with no health questions?
  • When should a buyer choose a different carrier over Transamerica for no-medical-exam final expense coverage?

Another option may be better in five situations, drawn from platform-reported alternative guidance.

First, when guaranteed acceptance is required and the buyer cannot or will not answer health questions [69]. Second, when the buyer needs a higher face amount than Transamerica's applicable limits [69]. Third, when the buyer's state, age, health profile, or distribution channel produces an unfavorable offer or makes the product unavailable [71]. Fourth, when another carrier provides a materially lower guaranteed premium for the same face amount and benefit design after comparing identical assumptions [72]. Fifth, when the buyer wants fully public consumer pricing, current policy forms, or clearer record-check disclosures before applying [69].

For buyers who want a broader view of how this carrier compares with others in the same category, the No-Medical-Exam Final Expense Insurance consensus index collects the full set of fit reviews. Buyers who want to compare adjacent coverage types can also review the wider life insurance directory.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Transamerica before signing a final expense policy?
  • Which underwriting tier and product form will Transamerica actually issue?

The following questions come directly from platform-reported verification lists and should be answered in writing before signing.

  1. What is the exact current product name and policy form being offered: Immediate Solution, 10-Pay Solution, Easy Solution, Express Select, or another form? [75]
  2. Will this application require only health questions, or may Transamerica obtain prescription histories, MIB data, electronic medical records, physician statements, or other third-party data? [75]
  3. Is a paramedical exam, blood test, urine test, or laboratory test possible if automated underwriting cannot decide the application? [75]
  4. What are the guaranteed monthly, quarterly, semiannual, and annual premiums for the desired face amount, including every policy fee and rider charge? [75]
  5. Which legal Transamerica entity will issue the policy in the buyer's state? [75]
  6. Is the desired product and face amount available in the buyer's state and through the selected agent or distribution channel? [79]
  7. Does the offer have an immediate full death benefit, or a graded benefit? If graded, what exactly is payable for each cause of death during each period? [75]
  8. Are the nursing-home, accelerated-death, accidental-death, children's, or other riders available, included, optional, or separately priced? [81]
  9. What are the policy's free-look period, surrender-value schedule, lapse and reinstatement rules, nonforfeiture options, and loan terms? [75]
  10. How long does approval usually take if the application is referred for additional records or manual underwriting? [75]

Final AI Consensus Verdict

Transamerica is a good fit for no-medical-exam final expense insurance, with qualifications that a buyer must resolve before purchase. Five of six platforms returning a usable fit assessment rated it "good"; one rated it "mixed." The core need is met: simplified-issue permanent whole life with level premiums, marketed as potentially approving without exams or labs, with decisions advertised in as little as 10 minutes [84].

The verdict is not "best." No-exam is not guaranteed issue [86]. Product naming is inconsistent across sources [88]. Consumer-specific pricing is not publicly verified, and the sample figures that exist conflict [90]. Complaint data is elevated, though attribution to final expense specifically is unproven [92]. State availability conflicts between sources [93].

Buyers who answer health questions, accept applicant-specific underwriting, and verify the exact product, tier, premium, and issuing entity before signing will find Transamerica a credible option. Buyers who need guaranteed acceptance or fully transparent public pricing should look elsewhere.

How This Review Was Produced

This review synthesizes fit assessments returned by 7 AI platforms asked to recommend carriers for a consumer who wants permanent final expense life insurance without a traditional paramedical examination involving blood or urine testing, is willing to answer health questions and allow prescription, medical, or electronic records to be considered, and wants a reputable carrier, reasonable premiums, permanent coverage, and an efficient application process.

Transamerica was named by all 7 platforms during ranking discovery and received a usable fit assessment from 6. Platform-reported research dates range from 2026-06-12 (deepseek) to 2026-09-22 (anthropic, grok, kimi, openai, perplexity); the authoritative run research date is 2026-09-21. Deepseek returned its assessment with search disabled, so its claims are model-reported rather than retrieved.

Methodology Limitations

Six of 7 included platforms returned a usable fit assessment, so the fit findings are not unanimous and should not be described as such. Platform mentions in the ranking stage count only platforms that named the entity during ranking discovery.

Platform-reported research dates differ from the authoritative run date and are provenance metadata, not independent proof of freshness. The supplied URLs were collected from platform responses and were not independently validated at the writing stage. Citations are platform-reported evidence, not independently verified facts.

Conflicting product names, pricing, and capabilities were not resolved by guessing; where sources conflict, this review describes the conflict and identifies what the buyer should verify. No-search model claims require explicit verification before being treated as current facts. Platform agreement on a recommendation does not establish product quality, claims performance, or suitability for any individual applicant.

Sources

Company-Owned Sources

  • Transamerica Final Expense Solutions Portfolio: https://cloud.email.transamerica.com/final-expense/
  • Transamerica official website: https://www.transamerica.com
  • Transamerica Simplifies Final Expense Insurance for Consumers and Agents: https://www.transamerica.com/press-release/transamerica-simplifies-final-expense-insurance-consumers-and-agents
  • Additional AI research evidence93 records
    1. AI research evidence record perplexity:c2
    2. AI research evidence record openai:c2
    3. AI research evidence record openai:c4
    4. AI research evidence record anthropic:7-9
    5. AI research evidence record anthropic:22-3
    6. AI research evidence record anthropic:34-9
    7. AI research evidence record anthropic:37-12
    8. AI research evidence record perplexity:c9
    9. AI research evidence record openai:c1
    10. AI research evidence record anthropic:2-1
    11. AI research evidence record grok:1
    12. AI research evidence record kimi:asurgo-transamerica
    13. AI research evidence record anthropic:2-11
    14. AI research evidence record kimi:consumeradviser-transamerica
    15. AI research evidence record anthropic:38-19
    16. AI research evidence record anthropic:2-12
    17. AI research evidence record deepseek:c2
    18. AI research evidence record grok:0
    19. AI research evidence record openai:c2
    20. AI research evidence record perplexity:c1
    21. AI research evidence record anthropic:37-12
    22. AI research evidence record perplexity:c9
    23. AI research evidence record anthropic:38-16
    24. AI research evidence record openai:c1
    25. AI research evidence record perplexity:c2
    26. AI research evidence record anthropic:5-6
    27. AI research evidence record anthropic:9-5
    28. AI research evidence record anthropic:6-1
    29. AI research evidence record openai:c4
    30. AI research evidence record openai:c1
    31. AI research evidence record anthropic:2-1
    32. AI research evidence record grok:1
    33. AI research evidence record perplexity:c2
    34. AI research evidence record anthropic:7-4
    35. AI research evidence record kimi:consumeradviser-transamerica
    36. AI research evidence record anthropic:34-13
    37. AI research evidence record anthropic:28-1
    38. AI research evidence record openai:c2
    39. AI research evidence record anthropic:13-6
    40. AI research evidence record anthropic:15-4
    41. AI research evidence record openai:c1
    42. AI research evidence record anthropic:38-16
    43. AI research evidence record anthropic:43-4
    44. AI research evidence record anthropic:2-13
    45. AI research evidence record anthropic:6-6
    46. AI research evidence record anthropic:41-5
    47. AI research evidence record openai:c3
    48. AI research evidence record anthropic:42-5
    49. AI research evidence record kimi:consumeradviser-transamerica
    50. AI research evidence record openai:c1
    51. AI research evidence record perplexity:c14
    52. AI research evidence record anthropic:38-19
    53. AI research evidence record perplexity:c2
    54. AI research evidence record openai:c1
    55. AI research evidence record anthropic:2-1
    56. AI research evidence record grok:0
    57. AI research evidence record kimi:asurgo-aflac
    58. AI research evidence record anthropic:7-5
    59. AI research evidence record openai:c1
    60. AI research evidence record perplexity:c9
    61. AI research evidence record perplexity:c2
    62. AI research evidence record openai:c3
    63. AI research evidence record grok:1
    64. AI research evidence record anthropic:7-5
    65. AI research evidence record kimi:consumeradviser-transamerica
    66. AI research evidence record anthropic:34-13
    67. AI research evidence record anthropic:28-1
    68. AI research evidence record anthropic:13-1
    69. AI research evidence record openai:c1
    70. AI research evidence record deepseek:c2
    71. AI research evidence record openai:c3
    72. AI research evidence record anthropic:7-5
    73. AI research evidence record grok:1
    74. AI research evidence record perplexity:c2
    75. AI research evidence record openai:c1
    76. AI research evidence record anthropic:2-1
    77. AI research evidence record anthropic:13-6
    78. AI research evidence record anthropic:37-12
    79. AI research evidence record openai:c3
    80. AI research evidence record anthropic:38-19
    81. AI research evidence record anthropic:2-13
    82. AI research evidence record anthropic:41-4
    83. AI research evidence record perplexity:c2
    84. AI research evidence record openai:c2
    85. AI research evidence record anthropic:5-6
    86. AI research evidence record anthropic:37-12
    87. AI research evidence record perplexity:c9
    88. AI research evidence record openai:c1
    89. AI research evidence record anthropic:2-1
    90. AI research evidence record anthropic:7-4
    91. AI research evidence record kimi:consumeradviser-transamerica
    92. AI research evidence record anthropic:34-13
    93. AI research evidence record openai:c3

Independent Sources

Other Sources

  • Additional AI research evidence93 records
    1. AI research evidence record perplexity:c2
    2. AI research evidence record openai:c2
    3. AI research evidence record openai:c4
    4. AI research evidence record anthropic:7-9
    5. AI research evidence record anthropic:22-3
    6. AI research evidence record anthropic:34-9
    7. AI research evidence record anthropic:37-12
    8. AI research evidence record perplexity:c9
    9. AI research evidence record openai:c1
    10. AI research evidence record anthropic:2-1
    11. AI research evidence record grok:1
    12. AI research evidence record kimi:asurgo-transamerica
    13. AI research evidence record anthropic:2-11
    14. AI research evidence record kimi:consumeradviser-transamerica
    15. AI research evidence record anthropic:38-19
    16. AI research evidence record anthropic:2-12
    17. AI research evidence record deepseek:c2
    18. AI research evidence record grok:0
    19. AI research evidence record openai:c2
    20. AI research evidence record perplexity:c1
    21. AI research evidence record anthropic:37-12
    22. AI research evidence record perplexity:c9
    23. AI research evidence record anthropic:38-16
    24. AI research evidence record openai:c1
    25. AI research evidence record perplexity:c2
    26. AI research evidence record anthropic:5-6
    27. AI research evidence record anthropic:9-5
    28. AI research evidence record anthropic:6-1
    29. AI research evidence record openai:c4
    30. AI research evidence record openai:c1
    31. AI research evidence record anthropic:2-1
    32. AI research evidence record grok:1
    33. AI research evidence record perplexity:c2
    34. AI research evidence record anthropic:7-4
    35. AI research evidence record kimi:consumeradviser-transamerica
    36. AI research evidence record anthropic:34-13
    37. AI research evidence record anthropic:28-1
    38. AI research evidence record openai:c2
    39. AI research evidence record anthropic:13-6
    40. AI research evidence record anthropic:15-4
    41. AI research evidence record openai:c1
    42. AI research evidence record anthropic:38-16
    43. AI research evidence record anthropic:43-4
    44. AI research evidence record anthropic:2-13
    45. AI research evidence record anthropic:6-6
    46. AI research evidence record anthropic:41-5
    47. AI research evidence record openai:c3
    48. AI research evidence record anthropic:42-5
    49. AI research evidence record kimi:consumeradviser-transamerica
    50. AI research evidence record openai:c1
    51. AI research evidence record perplexity:c14
    52. AI research evidence record anthropic:38-19
    53. AI research evidence record perplexity:c2
    54. AI research evidence record openai:c1
    55. AI research evidence record anthropic:2-1
    56. AI research evidence record grok:0
    57. AI research evidence record kimi:asurgo-aflac
    58. AI research evidence record anthropic:7-5
    59. AI research evidence record openai:c1
    60. AI research evidence record perplexity:c9
    61. AI research evidence record perplexity:c2
    62. AI research evidence record openai:c3
    63. AI research evidence record grok:1
    64. AI research evidence record anthropic:7-5
    65. AI research evidence record kimi:consumeradviser-transamerica
    66. AI research evidence record anthropic:34-13
    67. AI research evidence record anthropic:28-1
    68. AI research evidence record anthropic:13-1
    69. AI research evidence record openai:c1
    70. AI research evidence record deepseek:c2
    71. AI research evidence record openai:c3
    72. AI research evidence record anthropic:7-5
    73. AI research evidence record grok:1
    74. AI research evidence record perplexity:c2
    75. AI research evidence record openai:c1
    76. AI research evidence record anthropic:2-1
    77. AI research evidence record anthropic:13-6
    78. AI research evidence record anthropic:37-12
    79. AI research evidence record openai:c3
    80. AI research evidence record anthropic:38-19
    81. AI research evidence record anthropic:2-13
    82. AI research evidence record anthropic:41-4
    83. AI research evidence record perplexity:c2
    84. AI research evidence record openai:c2
    85. AI research evidence record anthropic:5-6
    86. AI research evidence record anthropic:37-12
    87. AI research evidence record perplexity:c9
    88. AI research evidence record openai:c1
    89. AI research evidence record anthropic:2-1
    90. AI research evidence record anthropic:7-4
    91. AI research evidence record kimi:consumeradviser-transamerica
    92. AI research evidence record anthropic:34-13
    93. AI research evidence record openai:c3

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 21, 2026
Platforms analyzed
7
Source records
35
Ranking mentions
7 of 7
Platform share
100%
Final consensus rank
#2

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

23 independent · 10 company-owned · 2 unclear

Evidence support

9 direct · 8 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

c1dc1a61849c55887a776ca262d882aedb4ae93defa5a4284eb0a07fee799296